Expert Insights, Tailored Networking, and Cutting-Edge Solutions Designed for Professionals Like You
MedTech Summit 2026 is the go-to event for Clinical & PMS Professionals seeking to navigate the complexities of clinical evaluations and post-market surveillance. Hear from industry leaders and peers about their approaches to guidance updates, cross-legislation impacts, and global reliance strategies.
Participate in practical case study sessions, stakeholder conversations, and roundtable discussions to gain actionable insights and streamline your approach. Connect with notified bodies and regulatory authorities to stay ahead of the curve and network with the wider MedTech regulatory community.
Tailored Programmes for Clinical & PMS Professionals to Enhance Clinical Evidence, Strengthen Post-Market Strategies, and Stay Ahead of MDR Requirements
Clinical Evaluations & PMS
Dive deep into the latest guidance updates, cross-legislation impacts, and global reliance strategies. Learn how to optimize clinical evaluation and PMS processes to enhance patient safety and regulatory compliance.
European Regulatory Affairs
Gain clarity on the EU Medical Device Regulation and its implications for clinical evaluations and PMS. Understand how MDR requirements shape your responsibilities and strategies.
Patient Access & Reimbursement Workshop
Explore the intersection of clinical data and market access. Learn how robust clinical evaluations and PMS can support reimbursement strategies and improve patient access.
Future Regulatory Leaders Linkup
Connect with emerging leaders in the regulatory space. Share insights and build relationships that can drive innovation and collaboration in clinical and PMS practices.
Clinical Evaluations & PMS Roundtable
Engage in focused discussions with peers, notified bodies, and regulatory authorities. Share experiences, challenges, and solutions to refine your approach to clinical evaluations and post-market surveillance.
Decode the Reforms: Real World Insights to Guide Your Next Move
The Future of Clinical Evidence in the Medical Device Lifecycle
Nebojsa Serafimovic, Assessor for Clinical Investigations, Austrian Medicines and Medical Device Agency, Austrian Federal Office for Safety in Health Care
Adam Kleinman, Associate Director, Medical & Scientific Writing, Philips
Tonia Jeiter, Senior Manager Clinical Evaluation and Clinical Lifecycle Management, Alcon
Barbara Fink, Associate Director of Clinical Affairs,Heartstream
Clinical Investigations in the UK – Delving into Past Insights and Future Opportunities
Mark Gumbridge, Head of Clinical Investigations, MHRA
Device Post-market Surveillance & Clinical Evidence for Drug-Device Combination Products
Josep Pané, Head of Device and Digital Vigilance and Safety, UCB